In the 2010 revision of the guidelines of the American Society of Clinical Oncology and the College of American Pathologists (ASCO/CAP), the cut-off value for the definition of hormone receptor positive breast cancers was reduced from 10 to 1% [4]. Here, NR4A1 is linked to breast cancer.